Albright Charles 4
4 · Editas Medicine, Inc. · Filed Dec 11, 2020
Insider Transaction Report
Form 4
Albright Charles
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2020-12-09$16.51/sh+10,000$165,100→ 34,907 total - Sale
Common Stock
2020-12-09$45.00/sh−10,000$450,000→ 24,907 total - Exercise/Conversion
Stock Option (right to buy)
2020-12-09−10,000→ 155,000 totalExercise: $16.51Exp: 2026-09-08→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]The exercise and sale reported in this Form 4 was effected pursuant to a 10b5-1 plan adopted by the Reporting Person on May 15, 2020.
- [F2]This option was granted on September 9, 2016 and vested over four years with 25% of the shares having vested on August 22, 2017, and the remaining 75% of the shares having vested in equal monthly installments thereafter through August 22, 2020.